Strategic Acquisition Position the combined MannKind and scPharmaceuticals entity as a growing cardiometabolic and respiratory specialty platform to target ongoing diligence and post-close integration opportunities, including cross-sell of pipeline products and expanded distribution.

Sale Process Clarity Leverage public disclosure of the proposed sale terms to align outreach around timeline, valuation milestones, and contingent value rights, offering readiness packages for potential buyers or strategic partners to accelerate due diligence.

Regulatory Milestones Highlight opportunities around regulatory and net sales milestone deliverables referenced in CVRs to craft focused outreach with CROs, contract manufacturing, and market access firms who can support milestone-driven partnerships.

Financial Leverage Offer financial and operational due diligence support to investors or acquirers by mapping current revenue bands, funding levels, and scalable manufacturing capabilities that could attract follow-on funding or bridge loans for expansion.

Operational Synergy Identify cross-functional synergies across enterprise software, compliance, and supply chain (as seen in the tech stack and SAP Concur usage) to propose integration services, ERP optimization, and data governance partnerships to improve post-merger efficiency.